Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 3
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2602.2500 25.40 (0.99%)

NSE Mar 18, 2025 15:31 PM

25.33% Fall from 52W High

Volume: 106.7K

Ajanta Pharma Ltd.

04 Nov 2022

2602.25

0.99%

Ajanta Pharma (HOLD): No respite from margin pressure; cut to HOLD

Hold: Ajanta Pharma Ltd.

BOB Capital Markets Ltd.

Q2 revenue growth muted at 6% YoY as lower Africa/US sales offset a strong uptick in India/Asia business

Number of FII/FPI investors increased from 346 to 373 in Dec 2024 qtr.